MMELX
Price
$18.42
Change
-$0.12 (-0.65%)
Updated
Sep 20 closing price
RRMGX
Price
$97.44
Change
-$0.69 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

MMELX vs RRMGX

Header iconMMELX vs RRMGX Comparison
Open Charts MMELX vs RRMGXBanner chart's image
MassMutual Mid Cap Growth Adm
Price$18.42
Change-$0.12 (-0.65%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth R
Price$97.44
Change-$0.69 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MMELX vs RRMGX Comparison Chart
Loading...
VS
MMELX vs. RRMGX commentary
Sep 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MMELX is a Buy and RRMGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 31.2B vs. MMELX (5.1B). MMELX (0.00) and RRMGX (0.00) have matching dividends . MMELX was incepted earlier than RRMGX: MMELX (24 years) vs RRMGX (22 years). MMELX is a more actively managed with annual turnover of: 32.00 vs. RRMGX (21.70). MMELX has a lower initial minimum investment than RRMGX: MMELX (0) vs RRMGX (2500). MMELX annual gain was more profitable for investors over the last year : 16.09 vs. RRMGX (13.62). RRMGX return over 5 years is better than : 9.23 vs. MMELX (-14.36).
MMELXRRMGXMMELX / RRMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years22 years-
Gain YTD10.6218.605123%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets5.1B31.2B16%
Annual Yield % from dividends0.000.00-
Returns for 1 year16.0913.62118%
Returns for 3 years-35.42-16.28218%
Returns for 5 years-14.369.23-156%
Returns for 10 years1.7633.745%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OII26.020.16
+0.62%
Oceaneering International
COTY9.19-0.20
-2.13%
COTY
CLCO11.05-0.30
-2.64%
Cool Company Ltd
QLGN0.17-0.01
-4.84%
Qualigen Therapeutics
PRPH2.34-0.17
-6.77%
ProPhase Labs